PT3097909T - Micropartículas administráveis in vivo através de tubo médico - Google Patents

Micropartículas administráveis in vivo através de tubo médico

Info

Publication number
PT3097909T
PT3097909T PT157400748T PT15740074T PT3097909T PT 3097909 T PT3097909 T PT 3097909T PT 157400748 T PT157400748 T PT 157400748T PT 15740074 T PT15740074 T PT 15740074T PT 3097909 T PT3097909 T PT 3097909T
Authority
PT
Portugal
Prior art keywords
vivo
medical conduit
administrable
microparticles
administrable microparticles
Prior art date
Application number
PT157400748T
Other languages
English (en)
Original Assignee
Nextbiomedical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nextbiomedical Co Ltd filed Critical Nextbiomedical Co Ltd
Publication of PT3097909T publication Critical patent/PT3097909T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
PT157400748T 2014-01-21 2015-01-21 Micropartículas administráveis in vivo através de tubo médico PT3097909T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140007089A KR101864465B1 (ko) 2014-01-21 2014-01-21 의료용 도관을 통한 생체 내 투여성 마이크로 입자

Publications (1)

Publication Number Publication Date
PT3097909T true PT3097909T (pt) 2020-11-25

Family

ID=53681663

Family Applications (1)

Application Number Title Priority Date Filing Date
PT157400748T PT3097909T (pt) 2014-01-21 2015-01-21 Micropartículas administráveis in vivo através de tubo médico

Country Status (9)

Country Link
US (1) US10004690B2 (pt)
EP (1) EP3097909B1 (pt)
JP (1) JP6306198B2 (pt)
KR (1) KR101864465B1 (pt)
CN (1) CN105934242B (pt)
ES (1) ES2833001T3 (pt)
PL (1) PL3097909T3 (pt)
PT (1) PT3097909T (pt)
WO (1) WO2015111914A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10441761B2 (en) 2016-07-01 2019-10-15 Boston Scientific Scimed, Inc. Delivery devices and methods
JP7126506B2 (ja) 2017-01-10 2022-08-26 ボストン サイエンティフィック サイムド,インコーポレイテッド 粉末薬剤を送達するための装置および方法
CN111587129A (zh) 2018-01-12 2020-08-25 波士顿科学国际有限公司 实现止血的粉末
US11766546B2 (en) 2018-01-31 2023-09-26 Boston Scientific Scimed, Inc. Apparatuses and methods for delivering powdered agents
EP4579371A3 (en) 2018-10-02 2025-12-24 Boston Scientific Scimed, Inc. Devices for fluidization and delivering a powdered agent
JP7447100B2 (ja) 2018-10-02 2024-03-11 ボストン サイエンティフィック サイムド,インコーポレイテッド 粉末剤を流動化して送達するための装置
US11918780B2 (en) 2019-12-03 2024-03-05 Boston Scientific Scimed, Inc. Agent administering medical device
EP4309564B1 (en) 2019-12-03 2026-01-28 Boston Scientific Scimed, Inc. Medical systems for agent delivery
US12053169B2 (en) 2019-12-03 2024-08-06 Boston Scientific Scimed, Inc. Devices and methods for delivering powdered agents
CN121512581A (zh) 2019-12-03 2026-02-13 波士顿科学国际有限公司 用于药物输送的医疗装置及相关使用方法
US12370353B2 (en) 2019-12-20 2025-07-29 Boston Scientific Scimed, Inc. Agent delivery device
US12465698B2 (en) 2020-01-06 2025-11-11 Boston Scientific Scimed, Inc. Devices and methods for delivering powdered agents
CN114901157B (zh) 2020-01-06 2025-08-12 波士顿科学国际有限公司 药剂输送系统
EP4106826A1 (en) 2020-02-18 2022-12-28 Boston Scientific Scimed, Inc. Hemostatic compositions and related methods
EP4076213B1 (en) 2020-03-06 2025-08-27 Boston Scientific Scimed, Inc. Devices for delivering powdered agents
AU2021241588B2 (en) 2020-03-24 2026-01-15 Boston Scientific Scimed, Inc. Agent delivery systems and methods of using the same
EP4135784A1 (en) 2020-04-17 2023-02-22 Boston Scientific Scimed, Inc. Hemostatic compositions and related methods
US12502488B2 (en) 2020-08-19 2025-12-23 Boston Scientific Scimed, Inc. Delivery device and methods of use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10306160A (ja) 1997-05-08 1998-11-17 Chisso Corp 低含水率ε−ポリリジンの製造方法
EP2060253A1 (en) * 2007-11-14 2009-05-20 Laboratorios Farmaceuticos Rovi, S.A. Pharmaceutical forms for the release of active compounds
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
CA2554994C (en) 2004-01-30 2015-05-19 Ferrosan A/S Haemostatic sprays and compositions
JP4439517B2 (ja) 2004-05-13 2010-03-24 株式会社ネクスト21 経内視鏡手術に用いる止血と、癒着の防止装置
KR20060040329A (ko) 2004-11-05 2006-05-10 나건 내시경을 통하여 도포 가능한 체내 지혈제 및 그 도포 방법
JP5223182B2 (ja) * 2005-10-27 2013-06-26 東レ株式会社 生分解性粒子およびその製造方法
CN104888264B (zh) * 2008-01-14 2018-01-09 北京环球利康科技有限公司 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
WO2009113512A1 (ja) 2008-03-11 2009-09-17 キユーピー株式会社 Socs3発現促進剤、これを含有する医薬品および食品、ならびにsocs3の発現を促進する方法
CA2716010C (en) * 2008-04-03 2019-10-01 Zymogenetics, Inc. Hemostatic microspheres
WO2009132229A2 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Cold ionizing radiation sterilization
AU2010252929B2 (en) * 2009-05-28 2015-08-27 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant
CN101862469B (zh) * 2010-05-28 2013-03-13 武汉人福医疗用品有限公司 一种壳聚糖衍生物快速止血颗粒及其制备方法
GB201021881D0 (en) 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
AU2012318259A1 (en) * 2011-10-11 2013-05-02 Baxter Healthcare S.A. Hemostatic compositions

Also Published As

Publication number Publication date
CN105934242B (zh) 2019-11-05
US10004690B2 (en) 2018-06-26
EP3097909B1 (en) 2020-10-21
PL3097909T3 (pl) 2021-01-25
US20160367482A1 (en) 2016-12-22
CN105934242A (zh) 2016-09-07
EP3097909A1 (en) 2016-11-30
JP6306198B2 (ja) 2018-04-04
KR20150086898A (ko) 2015-07-29
WO2015111914A1 (ko) 2015-07-30
JP2017503819A (ja) 2017-02-02
EP3097909A4 (en) 2017-06-28
ES2833001T3 (es) 2021-06-14
KR101864465B1 (ko) 2018-06-04

Similar Documents

Publication Publication Date Title
PT3097909T (pt) Micropartículas administráveis in vivo através de tubo médico
IL250685A0 (en) Medicinal substance induces cytotoxicity
PL3192451T3 (pl) Hak medyczny
SG11201703928QA (en) Patient interface
SG11201700489WA (en) Breast pump system and methods
SG11201700370YA (en) Breast pump system and methods
AU358462S (en) Patient interface
IL247072A0 (en) Medical use
PL3132034T3 (pl) Środek terapeutyczny
PL4137188T3 (pl) Interfejs do współpracowania z pacjentem
AU363953S (en) Curved tissue fastening device
EP3389593C0 (en) MEDICAL DELIVERY DEVICE
HUE065894T2 (hu) Bõrre rögzíthetõ orvostechnikai eszköz
SG11201701035SA (en) Cancer diagnosis and therapy
GB201413357D0 (en) Antibodies for treatment and diagnosis
GB201410816D0 (en) Therapeutic agents
GB201410216D0 (en) Therapeutic
SG11201608284XA (en) Medical imaging
GB201410815D0 (en) Therapeutic agents
GB201410817D0 (en) Therapeutic agents
GB201403032D0 (en) Medical device
GB201510637D0 (en) Therapeutic
PL2995730T3 (pl) Odpływ podłogowy z lejkiem wlotowym
GB201401806D0 (en) Novel methods for diagnosis and therapy
GB201410334D0 (en) Therapeutic